T-Cell Receptor Clonotype Mapping Using Denaturing Gradient Gel Electrophoresis View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2001

AUTHORS

Per thor Straten , JÜrgen C. Becker , Jesper Zeuthen , Per Guldberg

ABSTRACT

Melanoma cells are considered to be immunogenic because they express melanoma-associated antigens that are recognized by autologous T-cells. The role of T-lymphocytes in the host’s immune response to cancer in general and to melanoma in particular has been studied intensively during the past decade, and an immense amount of data have strengthened the notion that a functional and specific antimelanoma T-cell response operates in melanoma patients (1,2). This assumption has been strongly reinforced by the demonstration of clonotypic T-cells in both primary and metastatic melanoma (3,4). Nevertheless, the prognosis of metastatic melanoma is one of the most unfavorable in medicine. The coexistence of tumor-specific immunity with a progressing tumor remains a major paradox of tumor immunology and highlights the urgency to reveal new insights into the biology of antitumor T-cells. More... »

PAGES

339-351

Identifiers

URI

http://scigraph.springernature.com/pub.10.1385/1-59259-145-0:339

DOI

http://dx.doi.org/10.1385/1-59259-145-0:339

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1036088044

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22323267


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Tumor Cell Biology, Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark", 
          "id": "http://www.grid.ac/institutes/grid.5254.6", 
          "name": [
            "Department of Tumor Cell Biology, Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Straten", 
        "givenName": "Per thor", 
        "id": "sg:person.01000567066.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01000567066.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Dermatology, School of Medicine, W\u00dcrzburg, Germany", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Dermatology, School of Medicine, W\u00dcrzburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Becker", 
        "givenName": "J\u00dcrgen C.", 
        "id": "sg:person.010752465752.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010752465752.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Tumor Cell Biology, Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark", 
          "id": "http://www.grid.ac/institutes/grid.5254.6", 
          "name": [
            "Department of Tumor Cell Biology, Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zeuthen", 
        "givenName": "Jesper", 
        "id": "sg:person.013432725511.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013432725511.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Tumor Cell Biology, Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark", 
          "id": "http://www.grid.ac/institutes/grid.5254.6", 
          "name": [
            "Department of Tumor Cell Biology, Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guldberg", 
        "givenName": "Per", 
        "id": "sg:person.0760021664.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760021664.46"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2001", 
    "datePublishedReg": "2001-01-01", 
    "description": "Melanoma cells are considered to be immunogenic because they express melanoma-associated antigens that are recognized by autologous T-cells. The role of T-lymphocytes in the host\u2019s immune response to cancer in general and to melanoma in particular has been studied intensively during the past decade, and an immense amount of data have strengthened the notion that a functional and specific antimelanoma T-cell response operates in melanoma patients (1,2). This assumption has been strongly reinforced by the demonstration of clonotypic T-cells in both primary and metastatic melanoma (3,4). Nevertheless, the prognosis of metastatic melanoma is one of the most unfavorable in medicine. The coexistence of tumor-specific immunity with a progressing tumor remains a major paradox of tumor immunology and highlights the urgency to reveal new insights into the biology of antitumor T-cells.", 
    "genre": "chapter", 
    "id": "sg:pub.10.1385/1-59259-145-0:339", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-0-89603-684-0", 
        "978-1-59259-145-9"
      ], 
      "name": "Melanoma Techniques and Protocols", 
      "type": "Book"
    }, 
    "keywords": [
      "immune response", 
      "metastatic melanoma", 
      "cell receptor clonotype mapping", 
      "tumor-specific immunity", 
      "melanoma-associated antigens", 
      "host immune response", 
      "clonotype mapping", 
      "tumor immunology", 
      "melanoma patients", 
      "cell responses", 
      "clonotypic T", 
      "melanoma cells", 
      "melanoma", 
      "cells", 
      "patients", 
      "prognosis", 
      "lymphocytes", 
      "tumors", 
      "cancer", 
      "antigen", 
      "response", 
      "immunity", 
      "immunology", 
      "past decade", 
      "major paradox", 
      "medicine", 
      "gel electrophoresis", 
      "new insights", 
      "urgency", 
      "role", 
      "gradient gel electrophoresis", 
      "demonstration", 
      "data", 
      "biology", 
      "electrophoresis", 
      "decades", 
      "amount", 
      "insights", 
      "coexistence", 
      "immense amount", 
      "paradox", 
      "mapping", 
      "notion", 
      "assumption", 
      "specific antimelanoma T", 
      "antimelanoma T", 
      "Receptor Clonotype Mapping"
    ], 
    "name": "T-Cell Receptor Clonotype Mapping Using Denaturing Gradient Gel Electrophoresis", 
    "pagination": "339-351", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1036088044"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1385/1-59259-145-0:339"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22323267"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1385/1-59259-145-0:339", 
      "https://app.dimensions.ai/details/publication/pub.1036088044"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2021-11-01T18:49", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/chapter/chapter_177.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1385/1-59259-145-0:339"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1385/1-59259-145-0:339'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1385/1-59259-145-0:339'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1385/1-59259-145-0:339'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1385/1-59259-145-0:339'


 

This table displays all metadata directly associated to this object as RDF triples.

133 TRIPLES      22 PREDICATES      74 URIs      66 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1385/1-59259-145-0:339 schema:about anzsrc-for:11
2 anzsrc-for:1107
3 anzsrc-for:1112
4 schema:author Nc23ae7c9edc24265923e5118930ec2c5
5 schema:datePublished 2001
6 schema:datePublishedReg 2001-01-01
7 schema:description Melanoma cells are considered to be immunogenic because they express melanoma-associated antigens that are recognized by autologous T-cells. The role of T-lymphocytes in the host’s immune response to cancer in general and to melanoma in particular has been studied intensively during the past decade, and an immense amount of data have strengthened the notion that a functional and specific antimelanoma T-cell response operates in melanoma patients (1,2). This assumption has been strongly reinforced by the demonstration of clonotypic T-cells in both primary and metastatic melanoma (3,4). Nevertheless, the prognosis of metastatic melanoma is one of the most unfavorable in medicine. The coexistence of tumor-specific immunity with a progressing tumor remains a major paradox of tumor immunology and highlights the urgency to reveal new insights into the biology of antitumor T-cells.
8 schema:genre chapter
9 schema:inLanguage en
10 schema:isAccessibleForFree false
11 schema:isPartOf Nee3e69e2a3c14bc4ab5712fa7fa507d9
12 schema:keywords Receptor Clonotype Mapping
13 amount
14 antigen
15 antimelanoma T
16 assumption
17 biology
18 cancer
19 cell receptor clonotype mapping
20 cell responses
21 cells
22 clonotype mapping
23 clonotypic T
24 coexistence
25 data
26 decades
27 demonstration
28 electrophoresis
29 gel electrophoresis
30 gradient gel electrophoresis
31 host immune response
32 immense amount
33 immune response
34 immunity
35 immunology
36 insights
37 lymphocytes
38 major paradox
39 mapping
40 medicine
41 melanoma
42 melanoma cells
43 melanoma patients
44 melanoma-associated antigens
45 metastatic melanoma
46 new insights
47 notion
48 paradox
49 past decade
50 patients
51 prognosis
52 response
53 role
54 specific antimelanoma T
55 tumor immunology
56 tumor-specific immunity
57 tumors
58 urgency
59 schema:name T-Cell Receptor Clonotype Mapping Using Denaturing Gradient Gel Electrophoresis
60 schema:pagination 339-351
61 schema:productId N3dcc89b935304fbe9b208ac3002983a3
62 N9676774171d34ad783f4b53c1ba3824c
63 Na350e02c902d496885222dd1e49e73ad
64 schema:publisher N04755117b3354aec86bb873d05507582
65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036088044
66 https://doi.org/10.1385/1-59259-145-0:339
67 schema:sdDatePublished 2021-11-01T18:49
68 schema:sdLicense https://scigraph.springernature.com/explorer/license/
69 schema:sdPublisher Nb41828c468684e04af6340c88f037ed2
70 schema:url https://doi.org/10.1385/1-59259-145-0:339
71 sgo:license sg:explorer/license/
72 sgo:sdDataset chapters
73 rdf:type schema:Chapter
74 N04755117b3354aec86bb873d05507582 schema:name Springer Nature
75 rdf:type schema:Organisation
76 N1e9db843c1be4fb3a8b9205355b36c44 rdf:first sg:person.010752465752.66
77 rdf:rest N4af8c2f93531447683a80ac9efa00453
78 N3dcc89b935304fbe9b208ac3002983a3 schema:name dimensions_id
79 schema:value pub.1036088044
80 rdf:type schema:PropertyValue
81 N3f02e4eefc6b49909e78108671a30996 rdf:first sg:person.0760021664.46
82 rdf:rest rdf:nil
83 N4af8c2f93531447683a80ac9efa00453 rdf:first sg:person.013432725511.14
84 rdf:rest N3f02e4eefc6b49909e78108671a30996
85 N9676774171d34ad783f4b53c1ba3824c schema:name doi
86 schema:value 10.1385/1-59259-145-0:339
87 rdf:type schema:PropertyValue
88 Na350e02c902d496885222dd1e49e73ad schema:name pubmed_id
89 schema:value 22323267
90 rdf:type schema:PropertyValue
91 Nb41828c468684e04af6340c88f037ed2 schema:name Springer Nature - SN SciGraph project
92 rdf:type schema:Organization
93 Nc23ae7c9edc24265923e5118930ec2c5 rdf:first sg:person.01000567066.50
94 rdf:rest N1e9db843c1be4fb3a8b9205355b36c44
95 Nee3e69e2a3c14bc4ab5712fa7fa507d9 schema:isbn 978-0-89603-684-0
96 978-1-59259-145-9
97 schema:name Melanoma Techniques and Protocols
98 rdf:type schema:Book
99 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
100 schema:name Medical and Health Sciences
101 rdf:type schema:DefinedTerm
102 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
103 schema:name Immunology
104 rdf:type schema:DefinedTerm
105 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
106 schema:name Oncology and Carcinogenesis
107 rdf:type schema:DefinedTerm
108 sg:person.01000567066.50 schema:affiliation grid-institutes:grid.5254.6
109 schema:familyName Straten
110 schema:givenName Per thor
111 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01000567066.50
112 rdf:type schema:Person
113 sg:person.010752465752.66 schema:affiliation grid-institutes:None
114 schema:familyName Becker
115 schema:givenName JÜrgen C.
116 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010752465752.66
117 rdf:type schema:Person
118 sg:person.013432725511.14 schema:affiliation grid-institutes:grid.5254.6
119 schema:familyName Zeuthen
120 schema:givenName Jesper
121 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013432725511.14
122 rdf:type schema:Person
123 sg:person.0760021664.46 schema:affiliation grid-institutes:grid.5254.6
124 schema:familyName Guldberg
125 schema:givenName Per
126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760021664.46
127 rdf:type schema:Person
128 grid-institutes:None schema:alternateName Department of Dermatology, School of Medicine, WÜrzburg, Germany
129 schema:name Department of Dermatology, School of Medicine, WÜrzburg, Germany
130 rdf:type schema:Organization
131 grid-institutes:grid.5254.6 schema:alternateName Department of Tumor Cell Biology, Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark
132 schema:name Department of Tumor Cell Biology, Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark
133 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...